VivoSim Labs, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
VivoSim Labs, Inc. (VIVS) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 5.00 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-12
- VivoSim Labs, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 5.00M shares, a 614.29% increase year-over-year.
- VivoSim Labs, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 700.00K shares, a 22.22% decline year-over-year.
- VivoSim Labs, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-06-30 was 900.00K shares, a 47.06% decline year-over-year.
- VivoSim Labs, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-06-30 was 1.70M shares, a 15.00% decline year-over-year.
- VivoSim Labs, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2026 was 5.00M shares, a 614.29% increase from fiscal 2025.
- VivoSim Labs, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 700.00K shares, a 12.50% decline from fiscal 2024.
- VivoSim Labs, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 800.00K shares, a 50.00% decline from fiscal 2023.
- VivoSim Labs, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 1.60M shares, a 33.33% increase from fiscal 2022.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 5.00M shares 10-Q · filed 2026-08-12 | |||||||
| 2026-03-31 | 5.00M shares 10-K · filed 2026-07-14 | |||||||
| 2025-12-31 | 800.00K shares 10-Q · filed 2026-02-11 | |||||||
| 2025-09-30 | 700.00K shares 10-Q · filed 2025-11-06 | |||||||
| 2025-06-30 | 700.00K shares 10-Q · filed 2026-08-12 | |||||||
| 2025-03-31 | 700.00K shares 10-K · filed 2026-07-14 | |||||||
| 2024-12-31 | 800.00K shares 10-Q · filed 2026-02-11 | 9.50M shares 10-Q · filed 2025-02-19 | ||||||
| 2024-09-30 | 900.00K shares 10-Q · filed 2025-11-06 | 11.30M shares 10-Q · filed 2024-11-08 | ||||||
| 2024-06-30 | 900.00K shares 10-Q · filed 2025-08-12 | 11.10M shares 10-Q · filed 2024-08-05 | ||||||
| 2024-03-31 | 800.00K shares 10-K · filed 2024-05-31 | |||||||
| 2023-12-31 | 800.00K shares 10-Q · filed 2025-02-19 | |||||||
| 2023-09-30 | 1.00M shares 10-Q · filed 2024-11-08 | |||||||
| 2023-06-30 | 1.70M shares 10-Q · filed 2024-08-05 | |||||||
| 2023-03-31 | 1.60M shares 10-K · filed 2024-05-31 | |||||||
| 2022-12-31 | 1.50M shares 10-Q · filed 2024-02-08 | |||||||
| 2022-09-30 | 1.40M shares 10-Q · filed 2023-11-09 | |||||||
| 2022-06-30 | 2.00M shares 10-Q · filed 2023-08-10 | |||||||
| 2022-03-31 | 1.20M shares 10-K · filed 2023-07-14 | |||||||
| 2021-12-31 | 1.10M shares 10-Q · filed 2023-02-09 | |||||||
| 2021-09-30 | 700.00K shares 10-Q · filed 2022-11-10 | |||||||
| 2021-06-30 | 1.00M shares 10-Q · filed 2022-08-11 | |||||||
| 2021-03-31 | 1.00M shares 10-K · filed 2022-06-10 | |||||||
| 2020-12-31 | 800.00K shares 10-Q · filed 2022-02-14 | |||||||
| 2020-09-30 | 900.00K shares 10-Q · filed 2021-11-08 | |||||||
| 2020-06-30 | 600.00K shares 10-Q · filed 2021-08-06 | 12.00M shares 10-Q · filed 2020-08-10 | ||||||
| 2020-03-31 | 600.00K shares 10-K · filed 2021-06-15 | |||||||
| 2019-12-31 | 800.00K shares 10-Q · filed 2021-02-08 | 16.70M shares 10-Q · filed 2020-02-10 | ||||||
| 2019-09-30 | 1.00M shares 10-Q · filed 2020-11-05 | 19.50M shares 10-Q · filed 2019-11-07 | ||||||
| 2019-06-30 | 14.60M shares 10-Q · filed 2020-08-10 | |||||||
| 2019-03-31 | 12.10M shares 10-K · filed 2020-05-28 | 14.40M shares 10-K · filed 2019-06-03 | ||||||
| 2018-12-31 | 15.60M shares 10-Q · filed 2020-02-10 | |||||||
| 2018-09-30 | 17.80M shares 10-Q · filed 2019-11-07 | |||||||
| 2018-06-30 | 14.60M shares 10-Q · filed 2019-08-08 | |||||||
| 2018-03-31 | 14.40M shares 10-K · filed 2020-05-28 | 12.60M shares 10-K · filed 2018-05-31 | ||||||
| 2017-12-31 | 14.00M shares 10-Q · filed 2019-02-07 | |||||||
| 2017-09-30 | 15.40M shares 10-Q · filed 2018-11-08 | |||||||
| 2017-06-30 | 16.00M shares 10-Q · filed 2018-08-09 | |||||||
| 2017-03-31 | 12.40M shares 10-K · filed 2018-05-31 | |||||||
| 2016-12-31 | 12.70M shares 10-Q · filed 2018-02-08 | |||||||
| 2016-09-30 | 13.20M shares 10-Q · filed 2016-11-03 | 13.20M shares 10-Q · filed 2017-11-09 | ||||||
| 2016-06-30 | 11.60M shares 10-Q · filed 2017-08-09 | |||||||
| 2016-03-31 | 10.70M shares 10-K · filed 2018-05-31 | |||||||
| 2015-12-31 | 10.50M shares 10-Q · filed 2016-02-08 | 10.50M shares 10-Q · filed 2017-02-09 | ||||||
| 2015-09-30 | 10.50M shares 10-Q · filed 2016-11-03 | 10.50M shares 10-Q · filed 2016-11-03 | ||||||
| 2015-06-30 | 10.20M shares 10-Q · filed 2016-08-04 | |||||||
| 2015-03-31 | 8.60M shares 10-K · filed 2017-06-07 | |||||||
| 2014-12-31 | 8.20M shares 10-Q · filed 2016-02-08 | 8.20M shares 10-Q · filed 2016-02-08 | ||||||
| 2014-09-30 | 7.90M shares 10-Q · filed 2015-11-09 | 7.90M shares 10-Q · filed 2015-11-09 | ||||||
| 2014-06-30 | 7.80M shares 10-Q · filed 2015-08-10 | |||||||
| 2014-03-31 | 7.70M shares 10-K · filed 2016-06-09 | |||||||
| 2013-12-31 | 6.40M shares 10-Q · filed 2015-02-06 | 6.40M shares 10-Q · filed 2015-02-06 | ||||||
| 2013-09-30 | 6.90M shares 10-Q · filed 2014-11-07 | 6.90M shares 10-Q · filed 2014-11-07 | ||||||
| 2013-06-30 | 8.70M shares 10-Q · filed 2013-08-09 | |||||||
| 2013-03-31 | 8.90M shares 10-K · filed 2015-06-09 | |||||||
| 2012-12-31 | 15.20M shares 10-K · filed 2015-06-09 | 14.10M shares 10-K · filed 2013-03-15 | ||||||
| 2012-09-30 | 11.70M shares 10-Q · filed 2013-11-08 | 15.70M shares 10-Q · filed 2013-11-08 | ||||||
| 2012-06-30 | 25.90M shares 10-Q · filed 2013-08-09 | |||||||
| 2012-03-31 | 25.80M shares 10-K · filed 2015-06-09 | |||||||
| 2011-12-31 | 6.40M shares 10-K · filed 2014-06-10 | 5.30M shares 10-K · filed 2013-03-15 | ||||||
| 2010-12-31 | 0.00 shares 10-KT · filed 2013-05-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |